巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    ThermoGenesis Holdings

    THMO
    0.213
    0.000
    2.21%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・ThermoGenesis Holdings - 延遲價格・最後更新於 10/08 2:36
    最高位
    0.216
    最低位
    0.208
    開市價
    --
    前收市價
    0.217
    成交量(千)
    18.90
    成交額(百萬)
    0.04
    買入
    0.209
    賣出
    0.211
    每手股數
    --
    市值(百萬)
    6.66
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    2.500 - 0.090
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    ThermoGenesis Holdings
    證券代碼
    THMO.US
    所屬板塊
    Medical Devices
    公司業務
    ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.
    發行量
    11911784
    公司總部
    2711 Citrus Road
    公司網址
    https://www.thermogenesis.com
    公司電郵
    ir@thermogenesis.com
    公司電話
    +1 916 858-5100
    暫無內容

    關於

    ThermoGenesis Holdings(THMO.US)所屬的行業板塊為Medical Devices。
    ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.
    詳細公司背景可參考: https://www.thermogenesis.com